These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7605656)

  • 1. Radioprotective effect of local administration of lysine-vasopressin and triglycyl-lysine-vasopressin on the rectal mucosa in rats.
    Bjelkengren G; Aronsen KF; Augustsson NE; Borgström S; Lindström C; Nylander G
    Acta Oncol; 1995; 34(4):487-92. PubMed ID: 7605656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a suitable dosage of lysine-vasopressin and triglycyl-lysine-vasopressin, given in a gel-solution locally in the rectum of rats for possible radioprotective purposes.
    Bjelkengren G
    Acta Oncol; 1990; 29(8):1041-6. PubMed ID: 2278725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis.
    Machová A
    Physiol Res; 1992; 41(2):121-7. PubMed ID: 1286075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs.
    Blei AT; Groszmann RJ; Gusberg R; Conn HO
    Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
    Laudański T; Akerlund M
    Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between lysine vasopressin and a long-acting analogue (N alpha-triglycyl-lysine vasopressin) used as local hemostatic agents for conization.
    Rundqvist E; Allen D; Larsson G
    Acta Obstet Gynecol Scand; 1988; 67(4):301-5. PubMed ID: 3051878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
    Nilsson G; Lindblom P; Palmer B; Vernersson E; Aberg M
    Scand J Plast Reconstr Surg Hand Surg; 1987; 21(2):149-57. PubMed ID: 2961054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glypressin on human nasal mucosa.
    Bende M; Bake B; Flisberg K; Löth S; Ohlin P; Olsson P; Pipkorn U
    Acta Otolaryngol; 1986; 102(5-6):488-93. PubMed ID: 3788547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of burns. An experimental study comparing the effects on blood loss, hemodynamics and renal function.
    Vernersson E; Palmer B; Aberg M
    Scand J Plast Reconstr Surg; 1984; 18(3):285-90. PubMed ID: 6528231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers.
    Nilsson G; Lindblom P; Ohlin M; Berling R; Vernersson E
    Drugs Exp Clin Res; 1990; 16(6):307-14. PubMed ID: 2086166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns.
    Garner WL; Thomson PD; Moore NP; Rodriguez JL; Smith DJ
    J Burn Care Rehabil; 1993; 14(4):458-60. PubMed ID: 8408173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis.
    Prowse CV; Douglas JG; Forrest JA; Forsling ML
    Eur J Clin Invest; 1980 Feb; 10(1):49-54. PubMed ID: 6768567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin: vasopressin analog and novel drug for septic shock.
    Pesaturo AB; Jennings HR; Voils SA
    Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin increased the concentration of L-lactate in the rectal lumen in a patient with septic shock.
    Perner A; Jørgensen VL; Waldau T
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1054-7. PubMed ID: 15315626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
    Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G
    Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.
    Freeman JG; Cobden I; Lishman AH; Record CO
    Lancet; 1982 Jul; 2(8289):66-8. PubMed ID: 6123808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance.
    Ryckwaert F; Virsolvy A; Fort A; Murat B; Richard S; Guillon G; Colson PH
    Crit Care Med; 2009 Mar; 37(3):876-81. PubMed ID: 19237891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity.
    Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K
    Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.